Clinical Trials for COVID-19 Vaccines and Therapies

ProSciento’s clinical research unit (CRU) in Chula Vista, California, is prepared to conduct clinical trials for COVID-19 in healthy subject populations. For more information about expedited enrollment and start start, please visit https://prosciento.com/covid-19-trials/ .

 

Clinical Trial and Patient Treatment Continuity 

During these unprecedented times, ProSciento’s top priorities are patient and staff safety and clinical trial data integrity. We’re pleased to announce that clinical research activities have resumed across our CRO multi-center studies in accordance to amended protocols in compliance with FDA guidance and state and local mandates and in coordination with our clients, partners, and vendors.

Clinical research activities have also resumed at our specialty clinical research unit (CRU) in Southern California through strict on-site safety measures. Moreover, we have a 100% vaccination status for our CRU site staff who are in direct contact with study participants.

To ensure the safety of our staff and study participants, we have taken COVID-19 precautions extremely seriously. Safety measures instituted at our CRU include:

  • COVID-19 antigen and antibody testing protocols 
  • Clinic zoning independent entrance, exit and air flow system
  • MERV-13 HVAC airflow filtration system
  • Temperature and symptoms triage 
  • PPE for clinical staff and face clothes for subjects
  • Daily medical grade sanitation of clinic

For questions or additional information, please contact us at COVID-19@prosciento.com.  

FacebookTwitterLinkedIn